Market research

1-Bromo-8-phenylnaphthalene

Explore licenses

360iResearch introduction

1-Bromo-8-phenylnaphthalene: Executive Overview

1-Bromo-8-phenylnaphthalene is a specialized brominated polycyclic aromatic compound used primarily as a research and synthetic intermediate. Its relevance is linked to halogen-enabled cross-coupling, functional-materials chemistry, and the preparation of structurally defined aromatic molecules. Publicly available information supports a niche, technically demanding market shaped more by purity, documentation, and reliable supply than by mass-volume consumption.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Product Type

    • Intermediate
    • Raw Material
    • Research Grade
    View chapter
  2. Chapter 8 Purity Grade

    • Analytical Grade
    • Laboratory Grade
    • Technical Grade
    View chapter
  3. Chapter 9 Distribution Channel

    • Direct Sales
    • Distributors
    • Online Sales
    • Third-Party
    View chapter

Synthetic Chemistry and Compliance Are Reshaping the Landscape

The landscape is being shaped by increasing demand for reproducible building blocks, tighter control of impurity profiles, and more rigorous shipment documentation. Buyers increasingly evaluate identity confirmation, analytical certificates, packaging integrity, traceability, and continuity of supply alongside quoted price. Because the compound is a specialized research chemical, adoption depends on whether laboratories can obtain consistent material suitable for downstream reactions and regulated internal workflows.

Artificial Intelligence Improves Discovery, Quality Control, and Procurement

Artificial intelligence can accelerate reaction-condition screening, retrosynthetic analysis, spectral interpretation, and prioritization of aromatic building blocks. In quality operations, machine-learning tools may help identify anomalous chromatographic or spectroscopic results when trained on validated internal datasets. Procurement applications include catalog normalization, lead-time monitoring, and document retrieval; however, AI outputs require chemist review because predicted reactivity, impurity assignment, and regulatory classification can be unreliable for uncommon compounds.

Regional Insights: Specialized Demand Follows Research Infrastructure

North America and Europe benefit from established academic, pharmaceutical, and advanced-materials research ecosystems, while Asia-Pacific combines expanding chemical research capacity with strong manufacturing and export infrastructure. Latin America is supported by university and industrial laboratories but may face longer import cycles and documentation constraints. The Middle East is developing research and technology capabilities, with demand concentrated in specialized institutions. Africa remains more dependent on imported research chemicals and the availability of well-equipped laboratories. Across all regions, hazardous-material handling, customs classification, and dependable cold-chain or controlled-storage practices-where applicable-remain operational considerations.

Group Insights: Trade Rules and Research Networks Shape Access

ASEAN markets are influenced by regional manufacturing links, cross-border logistics, and uneven laboratory infrastructure. BRICS members combine major research and production capabilities with differing chemical-registration and import requirements. The European Union emphasizes harmonized chemical safety, documentation, and waste-management expectations. G7 economies generally provide strong analytical infrastructure and sophisticated procurement systems. GCC markets are developing research capacity and rely substantially on international supply channels. NATO members span diverse regulatory systems, but shared scientific networks and robust defense-adjacent materials research can support demand for specialized aromatic intermediates.

Country Insights: Demand Reflects Capability, Regulation, and Import Access

Australia supports the compound’s use through university and analytical research, although geographic distance can affect replenishment. Brazil and Mexico have broad academic and industrial bases but may encounter import and customs variability. Canada and the United States have mature research procurement and characterization capabilities. China, Japan, and South Korea combine advanced chemical research with strong materials and electronics ecosystems. India has expanding pharmaceutical, academic, and process-development activity. France, Germany, Italy, Spain, and the United Kingdom provide established research and specialty-chemical infrastructure within distinct national compliance frameworks. Russia has significant scientific capability, while access and cross-border trade conditions can affect sourcing options. Across these countries, buyers prioritize verified identity, consistent purity, safety documentation, and dependable delivery.

Actions for Leaders: Build Resilient, Evidence-Based Supply Programs

Industry leaders should qualify more than one technically credible source, define acceptance criteria for identity and purity, and retain complete certificates and batch records. Supplier audits should assess synthesis controls, analytical capability, packaging, change notification, and export documentation. Research teams can reduce delays by standardizing nomenclature, confirming regulatory classification before ordering, and aligning procurement with reaction-development schedules. Digital tools should support-not replace-expert review, particularly for spectral interpretation and hazard assessment. A documented contingency plan for customs delays, reformulation, and alternative synthetic routes can improve continuity without compromising laboratory standards.

Research Methodology: Evidence-Led Assessment of a Specialized Compound

This executive summary uses the compound identity and requested geographic scope as the analytical frame, then applies a qualitative assessment of established chemical-supply, research-infrastructure, regulatory, and logistics factors. Insights are limited to defensible structural observations about specialized research chemicals and synthetic intermediates. No market estimates, market shares, forecasts, or unverified company-specific claims are included. Regional, group, and country comparisons are presented as contextual interpretations rather than quantified rankings.

Conclusion: Reliability and Technical Assurance Define Competitive Advantage

1-Bromo-8-phenylnaphthalene occupies a specialized position where technical assurance is more important than broad consumer visibility. Demand conditions are linked to research activity, advanced synthesis, analytical confidence, and access to compliant international logistics. Suppliers and buyers that emphasize traceability, validated characterization, regulatory readiness, and continuity planning are best positioned to support responsible use of this compound across global research and development networks.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.1-Bromo-8-phenylnaphthalene Market, by Product Type
    1. 7.1Introduction
    2. 7.2Intermediate
    3. 7.3Raw Material
      1. 7.3.1Liquid
      2. 7.3.2Solid
    4. 7.4Research Grade
      1. 7.4.1Analytical Grade
      2. 7.4.2Technical Grade
  8. 8.1-Bromo-8-phenylnaphthalene Market, by Purity Grade
    1. 8.1Introduction
    2. 8.2Analytical Grade
      1. 8.2.198%+
      2. 8.2.299%+
    3. 8.3Laboratory Grade
    4. 8.4Technical Grade
      1. 8.4.190-95%
      2. 8.4.295-98%
  9. 9.1-Bromo-8-phenylnaphthalene Market, by Distribution Channel
    1. 9.1Introduction
    2. 9.2Direct Sales
    3. 9.3Distributors
      1. 9.3.1Global Distributors
      2. 9.3.2Local Distributors
    4. 9.4Online Sales
      1. 9.4.1Company Website
      2. 9.4.2Third-Party Platforms
    5. 9.5Third-Party
  10. 10.1-Bromo-8-phenylnaphthalene Market, by Application
    1. 10.1Introduction
    2. 10.2Fluorescent Probes
      1. 10.2.1Cellular Imaging
      2. 10.2.2Molecular Probes
    3. 10.3Organic Electronics
      1. 10.3.1Organic Field Effect Transistor
      2. 10.3.2Organic Light Emitting Diode
      3. 10.3.3Organic Solar Cell
    4. 10.4Pharmaceuticals
      1. 10.4.1Cardiovascular
      2. 10.4.2Neurology
      3. 10.4.3Oncology
    5. 10.5Research Chemicals
      1. 10.5.1Academic Institutions
      2. 10.5.2Contract Research Orgs
  11. 11.1-Bromo-8-phenylnaphthalene Market, by End-Use Industry
    1. 11.1Introduction
    2. 11.2Academic Institutions
      1. 11.2.1Chemistry
      2. 11.2.2Material Sciences
    3. 11.3Agrochemical Industry
      1. 11.3.1Crop Protection Companies
      2. 11.3.2Seed Treatment Companies
    4. 11.4Electronics Industry
      1. 11.4.1Oled Manufacturers
      2. 11.4.2Solar Cell Manufacturers
    5. 11.5Pharmaceutical Industry
      1. 11.5.1Large Pharma
      2. 11.5.2Small Pharma
  12. 12.1-Bromo-8-phenylnaphthalene Market, by Region
    1. 12.1Introduction
    2. 12.2Asia-Pacific
    3. 12.3North America
    4. 12.4Latin America
    5. 12.5Europe
    6. 12.6Middle East
    7. 12.7Africa
  13. 13.1-Bromo-8-phenylnaphthalene Market, by Group
    1. 13.1Introduction
    2. 13.2ASEAN
    3. 13.3GCC
    4. 13.4European Union
    5. 13.5BRICS
    6. 13.6G7
    7. 13.7NATO
  14. 14.1-Bromo-8-phenylnaphthalene Market, by Country
    1. 14.1Introduction
    2. 14.2United States
    3. 14.3Canada
    4. 14.4Mexico
    5. 14.5Brazil
    6. 14.6United Kingdom
    7. 14.7Germany
    8. 14.8France
    9. 14.9Russia
    10. 14.10Italy
    11. 14.11Spain
    12. 14.12China
    13. 14.13India
    14. 14.14Japan
    15. 14.15Australia
    16. 14.16South Korea
  15. 15.Competitive Landscape
    1. 15.1Market Share Analysis, 2025
    2. 15.2Market Concentration Analysis, 2025
      1. 15.2.1Concentration Ratio (CR)
      2. 15.2.2Herfindahl Hirschman Index (HHI)
    3. 15.3Recent Developments & Impact Analysis, 2025
    4. 15.4Product Portfolio Analysis, 2025
    5. 15.5Benchmarking Analysis, 2025
  16. 16.Company Profiles
    1. 16.1ABCR GmbH & Co. KG
    2. 16.2Ambeed, Inc.
    3. 16.3Arborpharmchem
    4. 16.4Avantor, Inc.
    5. 16.5Bide Pharmatech, Inc.
    6. 16.6BLD Pharmatech Ltd.
    7. 16.7Combi-Blocks, Inc.
    8. 16.8Echemi
    9. 16.9Enamine Ltd.
    10. 16.10Guidechem
    11. 16.11Hubei Jiutian Bio-medical Technology Co., Ltd.
    12. 16.12Key Organics Limited
    13. 16.13Matrix Scientific, LLC
    14. 16.14Merck KGaA
    15. 16.15Sigma-Aldrich
    16. 16.16Thermo Fisher Scientific Inc.
    17. 16.17Tokyo Chemical Industry Co., Ltd.
  17. 17.Key Experts

Loading the sample request form…